AskBio enters patent permit agreement with Pfizer for HCV therapy Asklepios BioPharmaceutical.

HCV infection may be the most common chronic blood-borne an infection in the usa, with approximately 3. 2 million people chronically contaminated. ‘This license represents another example of AskBio‘s progress in the advancement and commercialization of gene-delivery platform technology that focuses on creating worth for a broad range of therapeutic options for patients, including those with HCV.’.. AskBio enters patent permit agreement with Pfizer for HCV therapy Asklepios BioPharmaceutical, Inc. , a privately-owned clinical-stage biotechnology company, announced today it offers entered right into a patent permit agreement with Pfizer, Inc.Romm is an established expert in women’s wellness, women’s and pediatric botanical medication, and midwifery. She practiced as an herbalist and homebirth midwife and for over 20 years before becoming a physician, and was among the first certified professional midwives in the United States. Other books compiled by Dr. Romm are the Natural Pregnancy Book , Normally Healthy Babies and Children , ADHD Alternatives , and Natural Healing After Birth: The Complete Guidebook to Postpartum Wellness .